LEPR
Leptin receptor
Also known as: CD295, LEPR_HUMAN, OBR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48357
- Gene
- LEPR
- Ensembl
- ENSG00000116678
- Chromosome
- 1
- Canonical length
- 1165 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Vesicles,Plasma membrane,Primary cilium,Basal body,Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
1165 residues, UniProt reviewed canonical sequence.
>P48357|LEPR
1 MICQKFCVVL LHWEFIYVIT AFNLSYPITP WRFKLSCMPP NSTYDYFLLP AGLSKNTSNS
61 NGHYETAVEP KFNSSGTHFS NLSKTTFHCC FRSEQDRNCS LCADNIEGKT FVSTVNSLVF
121 QQIDANWNIQ CWLKGDLKLF ICYVESLFKN LFRNYNYKVH LLYVLPEVLE DSPLVPQKGS
181 FQMVHCNCSV HECCECLVPV PTAKLNDTLL MCLKITSGGV IFQSPLMSVQ PINMVKPDPP
241 LGLHMEITDD GNLKISWSSP PLVPFPLQYQ VKYSENSTTV IREADKIVSA TSLLVDSILP
301 GSSYEVQVRG KRLDGPGIWS DWSTPRVFTT QDVIYFPPKI LTSVGSNVSF HCIYKKENKI
361 VPSKEIVWWM NLAEKIPQSQ YDVVSDHVSK VTFFNLNETK PRGKFTYDAV YCCNEHECHH
421 RYAELYVIDV NINISCETDG YLTKMTCRWS TSTIQSLAES TLQLRYHRSS LYCSDIPSIH
481 PISEPKDCYL QSDGFYECIF QPIFLLSGYT MWIRINHSLG SLDSPPTCVL PDSVVKPLPP
541 SSVKAEITIN IGLLKISWEK PVFPENNLQF QIRYGLSGKE VQWKMYEVYD AKSKSVSLPV
601 PDLCAVYAVQ VRCKRLDGLG YWSNWSNPAY TVVMDIKVPM RGPEFWRIIN GDTMKKEKNV
661 TLLWKPLMKN DSLCSVQRYV INHHTSCNGT WSEDVGNHTK FTFLWTEQAH TVTVLAINSI
721 GASVANFNLT FSWPMSKVNI VQSLSAYPLN SSCVIVSWIL SPSDYKLMYF IIEWKNLNED
781 GEIKWLRISS SVKKYYIHDH FIPIEKYQFS LYPIFMEGVG KPKIINSFTQ DDIEKHQSDA
841 GLYVIVPVII SSSILLLGTL LISHQRMKKL FWEDVPNPKN CSWAQGLNFQ KPETFEHLFI
901 KHTASVTCGP LLLEPETISE DISVDTSWKN KDEMMPTTVV SLLSTTDLEK GSVCISDQFN
961 SVNFSEAEGT EVTYEDESQR QPFVKYATLI SNSKPSETGE EQGLINSSVT KCFSSKNSPL
1021 KDSFSNSSWE IEAQAFFILS DQHPNIISPH LTFSEGLDEL LKLEGNFPEE NNDKKSIYYL
1081 GVTSIKKRES GVLLTDKSRV SCPFPAPCLF TDIRVLQDSC SHFVENNINL GTSSKKTFAS
1141 YMPQFQTCST QTHKIMENKM CDLTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LEPR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 122 nTPM
Expression across tissuesHPA
Tissue
- liver: 122 nTPM
- tongue: 30 nTPM
- endometrium: 23 nTPM
- adipose tissue: 23 nTPM
- lung: 21 nTPM
- ovary: 21 nTPM
Single-cell type
- gastric chief cells: 252 nCPM
- fibroblasts: 238 nCPM
- hepatocytes: 226 nCPM
- podocytes: 205 nCPM
- vascular endothelial cells: 190 nCPM
- fibro-adipogenic progenitors: 189 nCPM
Immune cell
- basophil: 5 nTPM
- eosinophil: 1.3 nTPM
- T-reg: 1 nTPM
- classical monocyte: 0.9 nTPM
- myeloid DC: 0.7 nTPM
- neutrophil: 0.7 nTPM
Brain region
- choroid plexus: 52 nTPM
- hypothalamus: 25 nTPM
- thalamus: 14 nTPM
- spinal cord: 13 nTPM
- cerebral cortex: 13 nTPM
- midbrain: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LEPR.
Disease | AllUniProt
Conditions LEPR is implicated in, by any mechanism.
- Leptin receptor deficiency (LEPRD) MIM:614963
Disease | GeneticClinVar
34 pathogenic / likely-pathogenic of 526 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- LEPR-related disorder
- Obesity due to leptin receptor gene deficiency
- Obesity
- Early onset severe obesity
- Obesity due to congenital leptin deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.42
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- bone growth
- cell surface receptor signaling pathway
- cell surface receptor signaling pathway via STAT
- cholesterol metabolic process
- cytokine-mediated signaling pathway
- energy homeostasis
- energy reserve metabolic process
- glial cell proliferation
- gluconeogenesis
- glucose homeostasis
- glycogen metabolic process
- leptin-mediated signaling pathway
- multicellular organism development
- negative regulation of autophagy
- negative regulation of gluconeogenesis
- phagocytosis
- positive regulation of cell population proliferation
- positive regulation of cold-induced thermogenesis
- regulation of bone remodeling
- regulation of feeding behavior
- regulation of transport
- response to leptin
- sexual reproduction
- T cell differentiation
- transport across blood-brain barrier
Molecular functions
- cytokine binding
- cytokine receptor activity
- identical protein binding
- peptide hormone binding
- transmembrane signaling receptor activity
- leptin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Long hematopoietin receptor, Gp130 family 2, conserved site
- Short hematopoietin receptor, family 1, conserved site
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin C2-set-like, ligand-binding
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Fibronectin type III domain
- Ig-like C2-type domain
- Leptin receptor, immunoglobulin-like domain
- Obesity receptor immunoglobulin like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LEPR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LEPR as an antibody target. Whether an autoantibody or antibody against LEPR could matter depends on whether native LEPR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LEPR is annotated at the cell surface, where native LEPR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LEPR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...